Dr Yeyang Su, MS., MA., MSc, Ph.D

Dr Yeyang Su is an Associate Research Fellow at the Institute of Basic Medicine and Cancer, Chinese Academy of Sciences. Her research resides at the intersection of biomedicine, society and policy. With education and research backgrounds in genetics, bioethics and anthropology, she aims to use transdisciplinary research to deepen our understanding of anthropos in the contemporary, wherein our in-the-making relations and interactions with biomedical technologies play a critical role.  

To properly understand this process and their implications, especially on the long term, Dr Su considers it is crucial to understand and bring patients’ and citizens’ perspectives into the conceptualization, development and use of novel biomedicine and their relevant public policies. Employing her interdisciplinary research skills and connections with researchers, clinicians, policy makers and patients, Dr Su has investigated phenomena such as direct-to-consumer genetic testing and experimental use of cell-based therapies in and outside of China. More recently, she furthers this line of inquiry into rare diseases and childhood cancer.

Dr Su is member of institutional review board at Zhejiang Cancer Hospital and ethics committee of the Zhejiang Society for Mathematical Medicine. She is an elected member of the Youth Committee of Otorhinolaryngology Tumor, Zhejiang Anti-Cancer Association and of International Collaboration and Communication Group of the Medical Ethics Branch of the Chinese Medical Association. She also serves at iGEM’s Human Practices Committee.